OXAYDO Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Oxaydo, and what generic alternatives are available?
Oxaydo is a drug marketed by Zyla and is included in one NDA. There are two patents protecting this drug and one Paragraph IV challenge.
This drug has thirteen patent family members in six countries.
The generic ingredient in OXAYDO is oxycodone hydrochloride. There are nineteen drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the oxycodone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Oxaydo
A generic version of OXAYDO was approved as oxycodone hydrochloride by SPECGX LLC on June 30th, 2004.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for OXAYDO?
- What are the global sales for OXAYDO?
- What is Average Wholesale Price for OXAYDO?
Summary for OXAYDO
International Patents: | 13 |
US Patents: | 2 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 8 |
Clinical Trials: | 1 |
Drug Prices: | Drug price information for OXAYDO |
What excipients (inactive ingredients) are in OXAYDO? | OXAYDO excipients list |
DailyMed Link: | OXAYDO at DailyMed |
Recent Clinical Trials for OXAYDO
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Stanford University | Phase 3 |
Pharmacology for OXAYDO
Drug Class | Opioid Agonist |
Mechanism of Action | Full Opioid Agonists |
Paragraph IV (Patent) Challenges for OXAYDO
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
OXAYDO | Tablets | oxycodone hydrochloride | 5 mg and 7.5 mg | 202080 | 1 | 2012-02-07 |
US Patents and Regulatory Information for OXAYDO
OXAYDO is protected by two US patents.
Patents protecting OXAYDO
Methods and compositions for deterring abuse of opioid containing dosage forms
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Abuse deterrent compositions and methods of making same
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Zyla | OXAYDO | oxycodone hydrochloride | TABLET;ORAL | 202080-001 | Jun 17, 2011 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Zyla | OXAYDO | oxycodone hydrochloride | TABLET;ORAL | 202080-002 | Jun 17, 2011 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Zyla | OXAYDO | oxycodone hydrochloride | TABLET;ORAL | 202080-001 | Jun 17, 2011 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Zyla | OXAYDO | oxycodone hydrochloride | TABLET;ORAL | 202080-002 | Jun 17, 2011 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for OXAYDO
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Zyla | OXAYDO | oxycodone hydrochloride | TABLET;ORAL | 202080-002 | Jun 17, 2011 | ⤷ Sign Up | ⤷ Sign Up |
Zyla | OXAYDO | oxycodone hydrochloride | TABLET;ORAL | 202080-002 | Jun 17, 2011 | ⤷ Sign Up | ⤷ Sign Up |
Zyla | OXAYDO | oxycodone hydrochloride | TABLET;ORAL | 202080-001 | Jun 17, 2011 | ⤷ Sign Up | ⤷ Sign Up |
Zyla | OXAYDO | oxycodone hydrochloride | TABLET;ORAL | 202080-001 | Jun 17, 2011 | ⤷ Sign Up | ⤷ Sign Up |
Zyla | OXAYDO | oxycodone hydrochloride | TABLET;ORAL | 202080-001 | Jun 17, 2011 | ⤷ Sign Up | ⤷ Sign Up |
Zyla | OXAYDO | oxycodone hydrochloride | TABLET;ORAL | 202080-002 | Jun 17, 2011 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for OXAYDO
See the table below for patents covering OXAYDO around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 1694260 | PROCEDES ET COMPOSITIONS POUR EMPECHER UN ABUS DE FORMES PHARMACEUTIQUES CONTENANT DES OPIOIDES (METHODS AND COMPOSITIONS FOR DETERRING ABUSE OF OPIOID CONTAINING DOSAGE FORMS) | ⤷ Sign Up |
Spain | 2637338 | ⤷ Sign Up | |
Israel | 175863 | PHARMACEUTICAL COMPOSITIONS FOR DETERRING ABUSE OF OPIOID CONTAINING DOSAGE FORMS | ⤷ Sign Up |
European Patent Office | 2420225 | Procédés et compositions permettant d'empêcher l'abus d'opioïde contenant des formes de dosage (Methods and compositions for deterring abuse of opioid containing dosage forms) | ⤷ Sign Up |
Canada | 2547334 | PROCEDES ET COMPOSITIONS POUR EMPECHER UN ABUS DE FORMES PHARMACEUTIQUES CONTENANT DES OPIOIDES (METHODS AND COMPOSITIONS FOR DETERRING ABUSE OF OPIOID CONTAINING DOSAGE FORMS) | ⤷ Sign Up |
Israel | 221018 | שיטות ותכשירים להרתיע שימוש לרע בצורות מינון המכילות אופיאואיד (Methods and compositions for deterring abuse of opioid containing dosage forms) | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for OXAYDO
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1685839 | 92292 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |